Side-by-side comparison of AI visibility scores, market position, and capabilities
British consumer health company with £14B revenue; Lysol, Mucinex, Nurofen, and Durex brands managing Mead Johnson infant formula litigation while competing with P&G and J&J.
Reckitt is a British multinational consumer health and hygiene company producing market-leading brands including Nurofen (ibuprofen), Strepsils, Dettol, Lysol, Durex, Mucinex, Enfamil infant formula, and Woolite — competing across OTC health, hygiene and home, and nutrition categories. Listed on the London Stock Exchange (LSE: RKT) and headquartered in Slough, England, Reckitt generates approximately £14 billion ($17 billion) in annual revenue. The company has undergone significant portfolio reshaping, divesting its Infant Formula & Child Nutrition (IFCN) business in some markets and selling Mead Johnson Nutrition operations.\n\nReckitt's business is organized into two segments: Health (Nurofen, Strepsils, Gaviscon, Mucinex, DayQuil/NyQuil in North America) and Hygiene and Home (Lysol/Dettol disinfectants, Finish dishwasher tablets, Vanish stain remover, Air Wick). The Health segment benefits from strong brand equity in OTC medications that command premium pricing. The Hygiene segment's Lysol brand benefited significantly from COVID-19 disinfectant demand and has sustained elevated brand awareness post-pandemic.\n\nIn 2025, Reckitt faces ongoing challenges from its $2.4 billion acquisition of Mead Johnson (Enfamil) — the company has faced significant litigation related to NEC (necrotizing enterocolitis) lawsuits claiming preterm infant formula contributed to infant deaths, resulting in large court judgments against Reckitt in 2024. The company is managing these legal liabilities while continuing to run its core consumer health and hygiene portfolio. Reckitt competes with Procter & Gamble, Johnson & Johnson, and Haleon for OTC health and hygiene market share. The 2025 strategy focuses on its Power Brands in health and hygiene, cost efficiency, and resolving the Mead Johnson litigation exposure.
Walmart Inc., $680.985B revenue FY2025, $15.51B net income (+32.8%), e-commerce: $120.9B (+20.8%), +27% globally, +22% US, 10,771 stores worldwide (4,606 US Walmart, 602 Sam's Club), 90% US population within 10 miles, 438M monthly online visitors, 6.
Walmart is the world's largest retailer and the largest company by revenue in the United States, founded by Sam Walton in Rogers, Arkansas in 1962. Built on the principle of everyday low prices (EDLP) and relentless supply chain efficiency, Walmart transformed American retail and became the defining model for mass-market discount retailing globally. Its scale — spanning 10,771 stores across 20 countries under banners including Walmart, Sam's Club, and Flipkart — gives it unmatched purchasing power and logistics infrastructure that competitors cannot easily replicate.\n\nWalmart's business spans brick-and-mortar supercenters, neighborhood market stores, wholesale clubs through Sam's Club, and a rapidly growing e-commerce operation. E-commerce revenue reached $120.9 billion in FY2025, a 20.8% year-over-year increase, cementing Walmart as the clear #2 US e-commerce player behind Amazon. Walmart+ membership, the company's subscription loyalty program offering free delivery, fuel discounts, and Paramount+ streaming, continues to grow and is central to deepening customer relationships and increasing purchase frequency beyond the physical store.\n\nWalmart reported $680.985 billion in revenue for FY2025 with $15.51 billion in net income, a 32.8% increase in profitability reflecting operating leverage and margin expansion. Its advertising business, Walmart Connect, is a high-margin revenue stream growing over 25% annually, establishing Walmart as a significant player in retail media networks alongside Amazon Advertising and Kroger. The combination of physical scale, e-commerce momentum, and advertising revenue diversification makes Walmart uniquely positioned to compete in the next era of retail.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.